TAIPEI, Taiwan, Dec. 23, 2024 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugates (ADC) and active immunotherapies (4174. ...
Read MoreRIYADH, Saudia Arabia, Dec. 19, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) inaugurated the Advanced Hematology Diagnostics Laboratory under the patronage of Deputy CEO Dr. Björn Zoéga. The ...
Read MoreMitolyn is a natural dietary supplement designed to support individuals struggling with stubborn body fat. It contains natural ingredients that address the root cause of weight gain and accelerate the metabolism to support fat burning. The ...
Read MorePR Newswire HONG KONG, Dec. 23, 2024 HONG KONG, Dec. 23, 2024 /PRNewswire/ -- A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to School of Medicine at Shanghai Jiao Tong University ...
Read MorePR Newswire SHANGHAI, Dec. 22, 2024 SHANGHAI, Dec. 22, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, ...
Read MorePR Newswire FORT LAUDERDALE, Fla., Dec. 22, 2024 FORT LAUDERDALE, Fla., Dec. 22, 2024 /PRNewswire/ -- Bicycle accidents can leave victims with severe injuries and uncertainty about what steps to take next. The Law Offices of Jason Turchin ...
Read MorePR Newswire DANA POINT, Calif., Dec. 22, 2024 Patent leverages AI technology to improve patient outcomes and reduce cost of care DANA POINT, Calif., Dec. 22, 2024 /PRNewswire-PRWeb/ -- SecondOpinionExpert, Inc. (SOE), a leading ...
Read MorePR Newswire BOSTON, Dec. 21, 2024 Course Director: Deborah Gomez Kwolek, MD, FACP, FAMWA, MSCP and Course Co-Director: Mahmooda Qureshi, MD, MSCP Join keynote speakers Jan L. Shifren, MD, MSCP, Anna Cabeca, DO, FACOG, ABAARM, Heather Hirsch, ...
Read MorePR Newswire GAINESVILLE, Fla., Dec. 21, 2024 The Hollander Foundation, dedicated to supporting prostate cancer research, awarded its annual gift to Franklin Huang, M.D. of the UCSF School of Medicine. Dr. Huang's lab examines the genetics of ...
Read MorePR Newswire SHANGHAI, Dec. 21, 2024 SHANGHAI, Dec. 21, 2024 /PRNewswire/ -- YolTech Therapeutics today announced updated data from its ongoing Phase I/IIa clinical trial of YOLT-201, a first-in-class CRISPR/Cas9-based in vivo gene-editing ...
Read MorePR Newswire PLAINSBORO, N.J., Dec. 20, 2024 PLAINSBORO, N.J., Dec. 20, 2024 /PRNewswire/ -- Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) approved Alhemo® (concizumab-mtci) injection as a once-daily ...
Read MorePR Newswire SILVER SPRING, Md., Dec. 20, 2024 SILVER SPRING, Md., Dec. 20, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea ...
Read MorePR Newswire INDIANAPOLIS, Dec. 20, 2024 Averaging up to 20% of weight loss, adults taking Zepbound had at least 25 fewer breathing interruptions each hour as they slept Up to 50% of adults taking Zepbound no longer had symptoms ...
Read MorePR Newswire NEW YORK, Dec. 20, 2024 The new research from eye care nonprofit Orbis International, supported by Heidelberg Engineering, shows how telemedicine improves outcomes for children with retinoblastoma through e-learning and virtual ...
Read MorePR Newswire VANCOUVER, BC, Dec. 20, 2024 USA News Group CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 20, 2024 /PRNewswire/ -- USA News Group News Commentary – The American Cancer Society has published its ...
Read MorePR Newswire INCHEON, South Korea, Dec. 18, 2024 - Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development - Investment highlights ...
Read MorePR Newswire CARLSBAD, Calif., Dec. 19, 2024 CARLSBAD, Calif., Dec. 19, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA™ (olezarsen) as an ...
Read MorePR Newswire LOS ANGELES, Dec. 18, 2024 LOS ANGELES, Dec. 18, 2024 /PRNewswire/ -- Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward in the fight against pancreatic ...
Read MorePR Newswire BERKELEY HEIGHTS, N.J., Dec. 18, 2024 BERKELEY HEIGHTS, N.J., Dec. 18, 2024 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals ...
Read MorePR Newswire WASHINGTON, Dec. 18, 2024 Volunteer Doctors Introduce Health Assessment Report, Outlining Urgent Medical Solutions for Syria WASHINGTON, Dec. 18, 2024 /PRNewswire/ -- The Syrian American Medical Society (SAMS), global leader ...
Read MorePR Newswire SCOTTSDALE, Ariz., Dec. 18, 2024 Findings from retrospective chart review of patients with suspected Parkinson's disease and related disorders show the use of skin biopsy for detection of abnormal synuclein in cutaneous nerves ...
Read MorePR Newswire DETROIT, Dec. 18, 2024 Karmanos is the first in the world with access to this innovative treatment that uses radiofrequencies to target and shrink cancerous tumors DETROIT, Dec. 18, 2024 /PRNewswire/ -- The Barbara Ann ...
Read MorePR Newswire ALEXANDRIA, Va., Dec. 18, 2024 Co-authored by young leaders, "Breaking the Algorithm" outlines recommendations to promote healthier experiences across digital platforms ALEXANDRIA, Va., Dec. 18, 2024 /PRNewswire/ -- Mental ...
Read MorePR Newswire MIAMI, Dec. 18, 2024 Breakthrough Study Highlights SenoVax™'s Potential to Transform Cancer Treatment MIAMI, Dec. 18, 2024 /PRNewswire/ -- Immorta Bio Inc., a leader in longevity-focused biotechnologies, has announced the ...
Read MorePR Newswire DELRAY BEACH, Fla., Dec. 18, 2024 DELRAY BEACH, Fla., Dec. 18, 2024 /PRNewswire/ -- The global therapeutic drug monitoring market would expand at a compound annual growth rate (CAGR) of 8.4% from USD 2.30 billion in 2024 to USD ...
Read MorePR Newswire SAN DIEGO, Dec. 18, 2024 Pilot study testing innovative agent designed to provide guideline-concordant education believed to be the first clinical study to evaluate an AI Agent with actual AFib patients SAN DIEGO, Dec. ...
Read MorePR Newswire SAN DIEGO, Dec. 18, 2024 SAN DIEGO, Dec. 18, 2024 /PRNewswire/ -- Abilita Therapeutics, Inc. ("Abilita") today announced a global licensing and multi-target research collaboration with Finnish Orion Corporation ("Orion") focused ...
Read MorePR Newswire NORTH POLE, Alaska, Dec. 18, 2024 Naughty Canine Eats Santa's Head NORTH POLE, Alaska, Dec. 18, 2024 /PRNewswire/ -- Puppies will find and eat anything, even at the North Pole. Few, however, make a direct assault on the big ...
Read MorePR Newswire NEW YORK, Dec. 18, 2024 NEW YORK, Dec. 18, 2024 /PRNewswire/ -- American Skin Association (ASA) is pleased to announce its renewed partnership with the Sun Protection Outreach Teaching by Students (SPOTS) program. SPOTS is an ...
Read MorePR Newswire HOUSTON, Dec. 18, 2024 PsychPlus, a pioneering leader in mental health care with a vision to reduce the national suicide rate, is taking bold steps toward transforming the U.S. mental health landscape. The company, distinguished ...
Read MorePR Newswire SALEM, Mass., Dec. 18, 2024 The tentative agreement follows a powerful informational picket by nurses in October that pushed Mass General Brigham to stabilize the Salem RN workforce SALEM, Mass., Dec. 18, 2024 /PRNewswire/ -- ...
Read MorePR Newswire CHANHASSEN, Minn., Dec. 18, 2024 Life Time takes on fast food frenzy with free consumer app to support healthy living CHANHASSEN, Minn., Dec. 18, 2024 /PRNewswire/ -- Countering the latest fast-food frenzy of free giveaways ...
Read MoreCanada NewsWire MISSISSAUGA, ON, Dec. 18, 2024 The agreement is a critical step in ensuring paediatric patients living with NF1 PN have public access to Koselugo, the only approved therapy in Canada for this rare disease MISSISSAUGA, ON, ...
Read MoreSubscribe to our Free Newsletters!